Hong Kong stocks surged in early trading, with Lepu Medical-B (02157.HK) rising more than 4%. MRG003 is set to be included in breakthrough therapy designations, targeting hard-to-treat nasopharyngeal cancer.
Chinatimes Financial App learned that Lupe Bio-B (02157.HK) rose more than 4% in the morning session, as of press time, it rose 4.11% to HK$7.34, with a turnover of HK$30.16 million.
Latest
3 m ago
